Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction

European Journal of Heart Failure

Volumn 10, Issue 8, 2008, Pages 733-739

  Stumpf, Christian ^a   Seybold, Katrin ^a   Petzi, Sebastian ^a   Wasmeier, Gerald ^a   Raaz, Dorette ^a   Yilmaz, Atilla ^a   Anger, Thomas ^a   Daniel, Werner G ^a   Garlichs, Christoph D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Heart failure; Inflammation; Interleukin 10; Myocardial infarction

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFICACY; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HISTOPATHOLOGY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WEIGHT GAIN;

ANIMALS; CYTOKINES; ECHOCARDIOGRAPHY; HEART FAILURE; INTERLEUKIN-10; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; VENTRICULAR FUNCTION, LEFT;

EID: 46849108765     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.06.007     Document Type: Article

References (29)

1. Cowie M.R., Wood D.A., Coats A.J., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83 (2000) 505-510
2. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
3. Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
4. de Vries J.E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27 (1995) 537-541
5. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55 (2003) 241-269
6. Mallat Z., Heymes C., Ohan J., et al. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19 (1999) 611-616
7. Anguera I., Miranda-Guardiola F., Bosch X., et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J 144 (2002) 811-817
8. Bolger A.P., Sharma R., von Haehling S., et al. Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol 90 (2002) 384-389
9. Stumpf C., Lehner C., Yilmaz A., Daniel W.G., and Garlichs C.D. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure. Clin Sci (Lond) 105 (2003) 45-50
10. Escofier N., Boichot E., Germain N., et al. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung. Fundam Clin Pharmacol 13 (1999) 96-101
11. Nishio R., Matsumori A., Shioi T., Ishida H., and Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 100 (1999) 1102-1108
12. Gullestad L., Aass H., Fjeld J.G., et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103 (2001) 220-225
13. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
14. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Soc Echocardiogr 16 (2003) 1091-1110
15. Torre-Amione G., Stetson S.J., Youker K.A., et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100 (1999) 1189-1193
16. Baumgarten G., Kim S.C., Stapel H., et al. Myocardial injury modulates the innate immune system and changes myocardial sensitivity. Basic Res Cardiol 101 (2006) 427-435
17. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
18. de Waal Malefyt R., Haanen J., Spits H., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174 (1991) 915-924
19. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
20. Rennick D.M., and Fort M.M. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 278 (2000) G829-G833
21. Mostafa Mtairag E., Chollet-Martin S., Oudghiri M., et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc Res 49 (2001) 882-890
22. Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., and Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96 (1995) 2304-2310
23. Silvestre J.S., Mallat Z., Tamarat R., et al. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res 89 (2001) 259-264
24. Yang Z., Zingarelli B., and Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 101 (2000) 1019-1026
25. Kaur K., Sharma A.K., and Singal P.K. Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H106-113
26. Adamopoulos S., Parissis J.T., Paraskevaidis I., et al. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24 (2003) 2186-2196
27. Fedorak R.N., Gangl A., Elson C.O., et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 119 (2000) 1473-1482
28. Yu Y., Zhang Z.H., Wei S.G., et al. Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction. Circ Res 101 (2007) 304-312
29. Girndt M., Kaul H., Sester U., et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62 (2002) 949-955